collaboration playbook for advancing access and improving ...7:30 main conference registration and...

REGISTER AT WWW.CBINET.COM/IDN 800-817-8601

Media Partners:

5th Annual

IDN and Bio/Pharma Partnering Summit

October 5-7, 2020 • The Notary Hotel • Philadelphia, PA

Collaboration Playbook for Advancing Access and Improving Outcomes Across the Care Continuum

Innovative Models and Insights from Industry Stakeholders, Including:

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD, Jefferson College of Population Health, Thomas Jefferson University

William Wagner, Senior Healthcare Analyst, Vendor Management Center of Excellence, Blue Cross Blue Shield of Michigan

Ralph Tang, President, MD/VA IPA, WellCare Health Plans/Collaborative Health Systems

Jacob Jolly, Director, Strategy and Market Access Specialty Pharmacy Services, Vanderbilt University Medical Center

Kim Coppom, Senior Director, Account Management, Sobi

Timothy Paine, Vice President of Strategy and Relations, Fairview Health

Robert Guigley, Vice President, Market Access, Ambry Genetics

NEW THIS YEAR: 2 In-Depth Workshops

A. Specialty Pharmacy Integration B. Contracting with Employers

Partnering Meetings to Engage with Stakeholders and Cultivate Relationships

Exclusive Industry Intelligence Benchmarking Report

CAN’T-MISS CASE STUDIES AND PANEL DISCUSSIONS: • Achieving Success in Value-Based

Contracting and Healthcare Delivery — Essential Value-Based Capabilities, Tools and Services

• Successful Partnership on Display – Critical Insights to Optimize Collaboration

• Fairview’s New Approach to Partnerships

• Partnering with IDNs/ACOs/Payers for Population Health — Enhancing Quality Care, Reducing Waste and Optimizing Utilization

• Addressing Adherence in Specialty Pharmacy

Brought to you by

an informa business

REGISTER BY JULY 31, 2020 AND SAVE $200

REGISTER AT WWW.CBINET.COM/IDN • 800-817-8601

A GREAT PLACE TO MEET YOUR MARKET!Maximize your access to decision-makers and align your brand with the life sciences industry’s premier thought-leaders and industry

innovators. Informa Connect-CBI’s custom sponsorship programs are designed to support your organization’s overall business development and marketing initiatives through meaningful prospect and customer interactions, brand assertion campaigns and

content-rich thought-leadership opportunities. Capitalize on the life sciences community’s premier platform for peer-to-peer exchange, solution driven content and first-in-class networking opportunities. For more information on how to position your

company as a sponsor or exhibitor, contact Karen Hanover at 617-290-6113 or email [email protected].

ABOUT THE MEETINGDriven by payer reform, consumer demands and scientific advancements, the healthcare system is undergoing unprecedented transformation. The shift from volume to value-based payment and care delivery has driven industry stakeholders to reshape their approach and many have answered the call for personalized, convenient and coordinated patient care by collaborating and establishing partnerships to advance patient access and outcomes.

The IDN and Bio/Pharma Partnering Summit serves as a think-tank for industry pioneers to discuss the current state of affairs and latest collaborations by showcasing novel case studies and pilot programs that enhance care continuity, examine the patient journey and improve overall patient outcomes.

Market Dynamics Driving the Dialogue“There has been notable growth in health system-owned specialty pharmacies in the last four years, with 70% of IDNs reporting having a specialty pharmacy in 2019, up from 39% in 2016. HIRC estimates that up to 85% of IDNs could have their own specialty pharmacy by 2022.”

— Health Industries Research Companies, 2019

“About 30 million lives are covered by IDNs’ captive insurance plans, which represents nearly 10% of the insured U.S. population.”

— ZS Associates, 2018

“The shift towards value-based care is most often identified as the top market trend impacting IDNs as government and commercial payers continue to grow alternative payment programs, and in some cases are accelerating the pace to downside risk.”

— Health Industries Research Companies, 2019

WHO SHOULD ATTEND:You will benefit from attending this event if you are a manufacturer, IDN, health plan, specialty pharmacy, academic

medical center, data aggregator or service provider working in the following areas:

Market Access Institutional/Hospital Sales Contracts Partnering/Partnerships GPOs/IDNs/ACOs Commercial Affairs National Accounts/Managed Markets Product/Brand/Marketing Population Health Trade/Channel/Distribution Health Systems Pharmacy Services Legal/Counsel

Conference Sponsors:

DAY ONE MONDAY, OCTOBER 5, 20207:30 Main Conference Registration and

Continental Breakfast

8:30 Co-Chair’s WelcomeRichard Demers, Chief Administrative Officer Ambulatory Pharmacy Services, University of Pennsylvania Health SystemMark Fisher, Regional Account Manager, Shionogi Inc.

Stay on the Pulse of Market Dynamics and Industry Trends

8:45 OPENING KEYNOTE State of the Healthcare Industry — A Look at the Current Landscape and Emerging Trends in Total Patient Care• Identify and overcome key obstacles industry

currently faces on the cusp of a major election year and the political dynamics impacting the marketplace

• Analyze trends in the digital transformation and new advancements for industry over the last year

• Navigate how regulations change in the manufacturer and payer scene and how this alters the IDN landscape

• Predict what to expect in the coming year and with the election cycle in 2020

• Recognize the successes achieved in collaboration and understand how these partnerships can bolster advancements in patient satisfaction and engagement

William Wagner, Senior Healthcare Analyst, Vendor Management Center of Excellence, Blue Cross Blue Shield of Michigan

Innovative Models and Case Study Showcase for Successful Stakeholder Collaboration

9:30 STAKEHOLDER SPOTLIGHT Best Practices from IDNs and Manufacturers — Overall Strategies from Contracting to OperatingDuring this discussion, panelists from varying company sizes and therapeutic areas breakdown the key factors that led to industry advancements and accomplishments.• Panelists answer your burning questions

collected from the pre-conference survey as well as in-room Q&A

• Recognize the key takeaways for your unique situation and how you can model your operation for success

• Examine different types of risk share agreements and discern the benefits of outcome and value-based contracting and value-based outcomes

MODERATOR:Kim Coppom, Senior Director, Account Management, SobiPANELISTS:Richard Demers, Chief Administrative Officer Ambulatory Pharmacy Services, University of Pennsylvania Health SystemJacob Jolly, Director, Strategy and Market Access Specialty Pharmacy Services, Vanderbilt University Medical CenterGerard Taglianetti, Market Access, Strategy, and Analytics, Pfizer Inc.Meredith Holt, National Vice President of Sales, ExceleraRx

10:30 Networking and Refreshment Break

11:00 Achieving Success in Value-Based Contracting and Health Care Delivery —Essential Value-Based Capabilities, Tools and ServicesIn this session, overcome the stumbling blocks many accountable care organizations (e.g., Medicare MSSP and Commercial ACOs) continue to face in achieving the promising rewards of value-based transformation. Discuss how value-based transformation gives rise to new domain expertise and a need for new financial and clinical capabilities, tools and services. • Focus on risk contracting, payment models,

population health infrastructure and like-minded physician networks to deliver on the promises of Medicare, Medicaid and commercial value-based programs

• Examine the changing roles of primary care, independent and affiliated CINs/IPAs/IDNs and preferred provider networks of specialists and acute/post-acute/home health entities

• Explore innovative models in win/win risk contracting and payment, population health management and clinically integrated provider networks, and, how this creates opportunities for critical payer-provider collaboration

• Understand the essentials of a population health MSO infrastructure, including episodes of care and pharmacy management — Enabled by an integrated health IT platform for risk management, care coordination/management, and clinical quality/integration

Ralph Tang, President, WellCare Health Plans

11:45 Successful Partnership on Display — Critical Insights to Optimize CollaborationPartnerships between IDNs and bio/pharma manufacturers can be extremely beneficial to both parties involved if executed correctly. During this session, hear from two companies who have done this and prospered.


Case Study

• Hear best practices to overcome challenges to collaboration within and outside your organization

• Discuss how radical collaborations can create positive environments for a better patient experience

• Share lessons learned to design better patient-centric tools to drive enhanced patient access and outcomes

Sunita Patolia, Ph.D., Former Team Lead of Human-Centered Design, Connected Health Innovation, Partners Health Care

Matt Schumacher, Head Health Systems Strategy, UCB

12:30 Networking Luncheon

1:30 An Inside Look at Fairview’s New Approach to Partnerships Fairview took a different path when deciding how to partner with bio/pharma manufacturers and it has led to tremendous success.

• Witness how an innovative take on a popular TV show concept helped create long-lasting and mutually beneficial collaborations

• Apply this method by being more open about challenges and goals for the year, and open the floodgates to new exciting results

• Capitalize on current relationships, seek out new partnerships and share your struggles to find creative solutions

Tim Paine, VP, Pharma Strategy & Relations, Fairview Health

2:15 Partnering with IDNs/ACOs/Payers for Population Health — Enhancing Quality Care, Reducing Waste and Optimizing UtilizationIDNs spend millions of dollars annually on prior authorization alone and this burdens the whole hospital system. By aligning your goals and interests, partnerships can be more beneficial for all parties involved.

• Establish partnerships with IDNs/ACOs and payers to improve overall population health

• Integrate high-quality care while reducing waste in your hospital system

• Utilize tools that address the unmet medical needs in the patient community and are easy to use for quicker adoption

Robert Guigley, Vice President, Market Access, Ambry Genetics


Partnering Meetings Through this unique interactive segment,

network with industry colleagues to uncover and establish new partnerships.

3:30 Bring In Additional Value though Partnering with IDNsThere’s a monumental shift underway in healthcare that is changing the way in which services are rendered and paid. This shift directly affects how life sciences organizations must approach product development, release, sales force engagement, targeting and outreach. It also suggests a need to look for new ways of partnering with various stakeholders within the healthcare eco-system to deliver personalized, convenience and better-coordinated patient care that advances patient access and improves treatment outcomes. • Gain insight on how pharma companies can

add value by partnering with IDNs to help the industry better understand the patient populations for improved treatment outcomes

• Leverage social determinants of health data (SDOH) to identify high adherence risk patient populations

• Examine how SDOH data provides rich insights for pharma organizations and their healthcare ecosystem partners to help the industry develop relevant care plans, support programs, patient education, outreach and community partnering programs with the ultimate goal of improving compliance and overall health outcomes

Richard Morino, Director Strategic Solutions, LexisNexis Risk Solutions–Health Care

Convert Your Data into Knowledge and Power

4:15 Maximize and Leverage the Value of Data to Improve Operations and OutcomesDo you know what data you have and how valuable it can be? IDNs have a wealth of knowledge at their fingertips that could be used to learn more about their patients, providers and even their own operations. Real-world data has the potential to revolutionize the delivery of health care and bring on the digital transformation.• Hear from experts who analyze health record

data and turn it into insights • Learn how to take action and use data to

improve product pull through, the patient experience and outcomes

• See success in this area by reframing the way big data is thought about to improve outcomes, gain actionable insights to patient care and manage data efficiently

• Discuss the benefits big data can provide such as predicting your staffing needs, disease diagnosis, the most effective and most prescribed drugs and treatments, improved quality of life, what patients are most profitable, etc.

Tom Renshaw, Senior Director, Acentrus SpecialtyNeil Smiley, President and CEO, Loopback AnalyticsDavid Mitchell, Pharmacist Sr. Manager, University of California, Davis

5:00 Close of Day One

Networking, Wine and Cheese Receptionimmediately following the final session on day one


Case Study

Case Study

Case Study

DAY TWO TUESDAY, OCTOBER 6, 20207:45 Continental Breakfast

8:15 Co-Chair’s Welcome and Review of Day OneRichard Demers, Chief Administrative Officer Ambulatory Pharmacy Services, University of Pennsylvania Health SystemMark Fisher, Regional Account Manager, Shionogi Inc.

Spotlight on Population Health and Patient Outcomes

8:30 TRAILBLAZER TALK Improving Population Health on a Broad ScopeThe overall health of a population is the result of multiple social, economic and clinical determinants, and the ability of a health system to positively impact these groups will more than likely require a multivariate approach. With each IDN having a unique patient population with varying issues and needs, this session shines light on how groups across the country are attempting to tackle this issue.• Develop initiatives to improve population

health by assessing different population risks, socioeconomic factors, climate challenges and levels of access

• Hear from industry’s foremost experts on the front lines of improving overall population health and benchmark leading frameworks

• Delve into the solutions that are currently being leveraged across the country, from old school approaches to the newest technology advances

CONVERSATION CONTRIBUTORS

Matthew Malachowski, Pharm.D., BCPS, System Director, Population Health and Ambulatory Care, Ochsner Health PharmacyRichard Stefanacci, Medical Director, Population Health, Jefferson College of Population Health Ralph Tang, President, WellCare Health PlansJohn C. Robicsek, AVP Strategy, Business, and Program Development, Atrium Health

9:30 Addressing Adherence in Specialty PharmacyAdherence is critical in specialty pharmacy where high-cost drugs are becoming more prevalent. When patients do not comply with directions for prescriptions, the treatments are not effective and can end up causing more harm. After years of research there is now data to support the integrated care model as an effective way to improve this challenge.• Understand how Vanderbilt has pioneered

better ways to encourage adherence among patients with PAH

• Discover the calculatable value of correct adherence and what is lost in value due to inconsistency

• Implement the techniques used to mitigate barriers to treatment and correct adherence

Jacob Jolly, Director, Strategy and Market Access Specialty Pharmacy Services, Vanderbilt University Medical CenterElizabeth Cherry, Program Director, Trade Relations, Vanderbilt Specialty Pharmacy


10:45 Using IDN Data to Improve Prescription Capture Rate and Maximize Managed Care OpportunityHealth systems, manufacturers, and payers typically have a good understanding of their own internal data yet struggle to gain and understand data once the patient journey extends beyond their four walls. By creating an internal platform to combine known and capturable internal data with available external data the doors are opened to new insights and advancements for IDNs. The goal of this exchange is to explore the value of data to drive true provider, manufacturer, and payer opportunity and target a road map to future growth.

• Utilize data to improve IDNs prescription capture rate

• Transform data and market intelligence into effective strategies to enhance managed care goals

• Prepare for the future by preparing to exchange information with manufacturers and payers to gain market access

Scott Wink, Vice President, AmerisourceBergen

11:15 Illustrate the Value of Working with IDNs to Executive LeadershipGaining stakeholder buy-in from all parties, especially leadership, can be difficult and without it you are less likely to succeed. By displaying value to these crucial stakeholders, success can be achieved much easier.

• Gain insight into how manufacturers demonstrate value to executive leaders in the industry

• Invest in your partnerships now to gain trust and an inside advantage down the road and leverage your relationships for success

• Build confidence in the collaborative efforts between teams to create a pathway for progress and improvements in patient care

12:00 Networking Luncheon


Case Study

Attendee Acclaim for the IDN and Bio/Pharma Partnering Series:


1:15 Leverage New Technology to Solve Workflow IssuesIDNs have a goal of ensuring quality care to all patients and this can be challenging with several locations and staff dispersed among them. There is a lack of visibility, accountability, organization and clear communication with outdated tools and platforms that do not integrate efficiently. Create a consistent process that manages care across the whole healthcare continuum.• Improve patient care by promoting the use of

mobile technologies and integrating them into daily structures

• Deep dive into the corresponding benefits such as streamlined systems and processes, better utilization of resources, and standardized data recording

• Ensure an effortless roll out by handling communications in a consistent and clear fashion

2:00 Post-Acute World — How Do You Engage with Patients After They Leave Your Facility?Every health system has a goal of reducing readmissions, providing an excellent patient experience and improving overall population health. A key component of this is preventative care and catching risks early. Post-acute care providers have the opportunity to differentiate their performance through a robust discharge follow-up program for targeted patients. This is the new standard of excellence in patient care — Managing the care after the patient is no longer directly under your care.• Engage and interact with patients and gain

new information in new ways by utilizing the technology transformation

• Discover how telehealth is changing the healthcare landscape for patients all around the world, even in the poorest and most challenging conditions and environments

• Share new innovative ways this can be accomplished such as: new apps with 2-way communication, telehealth, tech wearables, etc.

Glen Roebuck, Executive Director, Home Outpatient and Senior Living Service, Genesis Health System


3:15 THINK TANK Develop Standards for Measuring Patient OutcomesAs the industry shifts from volume-based care to value-based care, one of the cornerstones of the triple aim is improving patient outcomes. Ways to achieve this goal are endless, but first industry needs to define standard patient outcomes in a universal format. During this session, demystify the topic of measuring patient outcomes.• Assess strategies for measuring outcomes to

gauge effectiveness• Develop disease specific outcomes and

recognize disease states on a grand scale• Identify what you are measuring to illustrate

value and track ROIFACILITATORS: Tim Paine, VP, Pharma Strategy & Relations, Fairview HealthJami Schell, Director of Pharmaceutical Accounts, ExceleraRx

Exclusive Benchmarking Report Reveal

4:00 Industry Intelligence on the State of the Bio/Pharma and IDNsBenefit from a comprehensive wrap-up of benchmarking results representing the collective intelligence of the community comprised of a sampling of companies. Content of the survey covers leading strategies and critical areas of focus.Richard Demers, Chief Administrative Officer Ambulatory Pharmacy Services, University of Pennsylvania Health SystemMark Fisher, Regional Account Manager, Shionogi Inc.

5:00 Close of Day Two

Networking, Wine and Cheese Receptionimmediately following the final session on day two

“The knowledge base and experience of the attendees exceeded my expectations. The conference truly was a working session more than

a speaker’s conference.” — Curant Health

“The Partnering with IDNs conference was a wonderful

experience. What a great opportunity for industry leaders to come together and examine real world data. I will definitely

be a return attendee.” — TrellisRx

“Consistently, the Partnering with IDNs conference

pushes my thinking into the future and provides a view of what is

“around the corner” in healthcare. Additionally, the contacts I have

made across multiple disciplines and aspects of healthcare have

made a documentable difference in improved patient outcomes.”

— Sanofi

DAY THREE — WEDNESDAY, OCTOBER 7, 20208:00 Continental Breakfast

8:30 ATTENDEES CHOOSE BETWEEN TWO INCLUSIVE WORKSHOPS (A–B)


Workshop Objective: This workshop is divided into two main sections. Each section features a case study, discussion on operational models and best practices from the workshop leaders, as well as an interactive case study with group presentations. Part one focuses on developing an integrated specialty pharmacy model and part two focuses on innovative approaches to specialty pharmacy care delivery.

I. Developing an Integrated Specialty Pharmacy Model

Specialty pharmacy programs are a leading strategic initiative for health systems and pharmacy leaders, as their strong clinical outcomes drive significant financial value to the health system. This interactive working session explores common considerations pharmacy and executive leaders must evaluate in developing an effective specialty pharmacy business model. Through established pharmacy leaders from large academic medication centers to rural IDNs, learn how to build and optimize a specialty pharmacy within your health system.

Objectives:• Identify key steps in evaluating

opportunity to develop a business plan for the “C” suite

• Outline the framework for a specialty pharmacy program to focus on meaningful financial and clinical outcomes

• Develop revenue cycle management and financial reporting strategies to create and sustain a robust specialty pharmacy business

• Explore operational considerations for developing an efficient specialty pharmacy service line, including cold chain management and accreditation

II. Innovative Approaches to Specialty Pharmacy Care Delivery

IDN specialty pharmacies are the fastest growing segment of the specialty pharmacy market. Hear how meaningful collaboration between patients, providers, and the specialty pharmacy drives both effective clinical outcomes and superior patient and provider satisfaction. This interactive session explores novel approaches to delivering specialty pharmacy services in a rapidly evolving market.

Objectives:• Examine the current state of IDN

specialty pharmacies in urban and rural environments

• Discuss strategies to optimize capture, create new lines of business and establish scalable, yet sustainable processes

• Evaluate opportunities to leverage health system integration to differentiate your specialty pharmacy from market competitors

• Explore new lines of business beyond traditional specialty pharmacy

Workshop Leaders: Bhavesh Shah, Director of Specialty and Hematology and Oncology Pharmacy, Boston Medical CenterAlexander Pham, Director, Pharmacy Strategy and Business Development, Boston Medical CenterMatthew Marston, Director of Specialty Pharmacy, Northern Light Pharmacy Bernice Man, Practice Coordinator, Northwestern Medicine

12:00 Close of Conference

A. Specialty Pharmacy Integration

B. Contracting with Employers

*There will be a 30-minute Networking and Refreshment Break at 10:00

Workshop Objective: IDNs are increasingly taking on the role of payer through direct employer contracting, health plan ownership and risk-based contracting with insurers. There has been a dramatic increase in the trend of employers bypassing traditional insurers to contract directly with IDNs. Traditional MCOs are fighting to regain control and combat the influence of IDNs in retort to IDNs’ growing power on the delivery of healthcare.

Key Questions to Be Addressed:• How do employers view value

and where do they differ from payers?

• Can pharma contract directly with employers? Is this the next step for value-based contracting?

• Will contracting directly with employers put more emphasis and focus on patient centered care and improve patient outcomes?

• How can multi-purchaser and multi-payer efforts drive health system transformation?

Workshop Outline:I. Discuss Key Outcomes and

Lessons LearnedII. Spotlight on Guiding Principles

for Employers III. Examine and Assess Risk

Sharing Agreements • Analyze the benefits and

obstacles in various risk sharing agreements

• Evaluate the several different types of contracts that have emerged recently

Workshop Leaders:Joe Maher, Director of Value-Based Products, Henry Ford Allegiance HealthDr. Courtland Keteyian, President and CEO, Jackson Health NetworkMichael Baldzicki, Executive Vice President, Growth and Strategy, AscellaHealth

WEBwww.cbinet.com/idn

[email protected]

PHONE800-817-8601339-298-2100 outside the U.S.

LIVE CHATwww.cbinet.com/idn

WAYS TO REGISTER NOW!

SCAN HERE

Informa Connect-CBI 70 Blanchard Road Burlington, MA 01803

5th Annual IDN and Bio/Pharma Partnering Summit PC20400

VENUE: The Notary Hotel 21 N Juniper St

Philadelphia, PA 19107

Hotel Direct Line: 215-496-3200

ACCOMMODATIONS: To receive Informa Connect-CBI’s special discounted hotel rate online, please

go to: www.cbinet.com/idn

Book Now! For hotel room availability and direct booking links, please visit www.cbinet.com/idn and select the Venue-Pricing tab. Rooms are limited so please book early. All travel arrangements are subject to availability.

PLEASE NOTE: All hotel reservations for this conference should be booked directly with the hotel. Informa Connect-CBI does not use Housing Bureaus and none are authorized to call on our behalf.

REGISTRATION FEE: ADVANTAGE PRICING Standard Onsite IDNs/ACOs/Health Systems $1399 $1599 $1699 Life Sciences Companies $2499 $2699 $2799 Vendors/Consultants/Solution Providers $2899 $3099 $3199

Register by July 31, 2020 and SAVE $200. Fee includes continental breakfast, lunch, wine and cheese reception, refreshments and conference documentation. Credit Card (Visa, MC, AMEX, Discover) or checks accepted. Please make checks (in U.S. funds drawn on a U.S. bank) payable to: CBI. (No personal checks accepted.) PLEASE NOTE: All advertised discounts are taken from the full, Standard Rate.

GROUP RATE: Looking to bring your team? Contact Information Services to learn about potential group savings. Call 800-817-8601 or email [email protected]. * Advantage pricing rates do apply when applicable. Offer may not be combined with any other special pricing promotions. Offer may be used at Informa Connect-CBI co-located events.

SATISFACTION GUARANTEED: Informa Connect-CBI stands behind the quality of its conferences. If you are not satisfied with the quality of the conference, a credit will be awarded towards a comparable Informa Connect-CBI conference of your choice. Please contact 800-817-8601 for further information. Advanced preparation for Informa Connect-CBI conferences is not required.

SUBSTITUTION AND CANCELLATION: Your registration may be transferred to a member of your organization up to 24 hours in advance of the conference. All cancellations received in writing on or before 14 days prior to the start date of the event will be refunded, less a $499 administrative charge. No refunds will be made after this date; however, the registration fee less the applicable administrative charge can be credited to another Informa Connect-CBI conference if you register within 30 days from the date of this conference to an alternative Informa Connect-CBI conference scheduled within the next six months. In case of conference cancellation, Informa Connect-CBI’s liability is limited to refund of the conference registration fee only. Cancellation of a conference due to events beyond our control* are subject to a $499 administrative charge, should you or a colleague be unable to attend the rescheduled date. Informa Connect reserves the right to alter this program without prior notice. Please Note:Speakers and agenda are subject to change. In the event of a speaker cancellation, every effort to find a suitable replacement will be made. The opinions of the conference faculty do not necessarily reflect those of the companies they represent or Informa Connect-CBI.

*Events beyond our control include: severe weather conditions, natural and man-made disasters and any other similar events.

REGISTER AT WWW.CBINET.COM/IDN 800-817-8601

5th Annual

IDN and Bio/Pharma Partnering Summit

October 5-7, 2020 • The Notary Hotel • Philadelphia, PA

Collaboration Playbook for Advancing Access and Improving Outcomes Across the Care Continuum

ANY QUESTIONS OR TO REGISTER CONTACT:

Stuart Steller phone 339-298-2158 email [email protected]

REGISTER BY JULY 31, 2020 AND SAVE $200

collaboration playbook for advancing access and improving ...7:30 main conference registration and...

Documents